Merck (MRK) Cash from Investing Activities (2009 - 2026)

Merck (MRK) has reported Cash from Investing Activities for 18 consecutive years, with -$10.2 billion the latest figure, recorded in Q1 2026.

• In Q1 2026, Cash from Investing Activities fell 586.62% year-over-year to -$10.2 billion; the TTM figure through Mar 2026 stood at -$22.5 billion (down 186.35% YoY), while the FY2025 annual figure was -$13.7 billion, down 77.67% from the prior year.
• Cash from Investing Activities improved to -$10.2 billion in Q1 2026 per MRK's latest filing, from -$11.2 billion in the prior quarter.
• Across five years, Cash from Investing Activities topped out at $53.0 million in Q4 2023 and bottomed at -$11.4 billion in Q2 2023.
• Historically, Cash from Investing Activities has averaged -$3.0 billion across 5 years, with a median of -$1.4 billion in 2024.
• Annual changes were most pronounced in 2023 — Cash from Investing Activities soared 103.03% — and 2024, when it sank 2824.53%.
• Merck's Cash from Investing Activities stood at -$1.7 billion in 2022, then soared by 103.03% to $53.0 million in 2023, then tumbled by 2824.53% to -$1.4 billion in 2024, then slumped by 675.69% to -$11.2 billion in 2025, then increased by 8.85% to -$10.2 billion in 2026.
• Business Quant data shows MRK's Cash from Investing Activities at -$10.2 billion in Q1 2026, -$11.2 billion in Q4 2025, and -$283.0 million in Q3 2025.